NEW DELHI, Jan 2: Drug firm Hetero Wednesday said its European subsidiary Amarox has acquired Spain-based Tarbis Farma from Grupo Ferrer Internacional for an undisclosed amount.
Commenting on the development, Hetero Labs Executive Director A V Narasa Reddy said: “This acquisition fits well with Hetero’s growth strategy in EU giving Amarox a platform to reach out to the customers in a robust way with the present portfolio and Hetero’s pipeline of products.”
The company, however, did not provide any financial details of the acquisition.
Tarbis Farma comes with a robust product portfolio and an extensive marketing network with well-experienced personnel in retail business across Spain, Hetero said.
The acquisition enables Hetero with a strong front-end marketing presence giving Amarox the required commercial infrastructure, product portfolio, manpower and a seamless entry into the retail, hospital and tender business channels in Spain, it added.
Hetero currently has 36 manufacturing facilities worldwide and has presence in over 126 countries. (PTI)
Follow our WhatsApp channel
